IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.341
EU - Europa 31.994
AS - Asia 12.984
SA - Sud America 2.512
AF - Africa 194
Continente sconosciuto - Info sul continente non disponibili 151
OC - Oceania 28
Totale 88.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.119
RU - Federazione Russa 9.234
GB - Regno Unito 7.570
SG - Singapore 6.463
IT - Italia 4.588
DE - Germania 2.651
UA - Ucraina 2.541
CN - Cina 2.343
BR - Brasile 2.193
CA - Canada 1.971
HK - Hong Kong 1.696
DK - Danimarca 1.575
VN - Vietnam 1.210
SE - Svezia 855
IE - Irlanda 717
FI - Finlandia 614
FR - Francia 565
PL - Polonia 332
NL - Olanda 231
IN - India 220
TR - Turchia 173
MX - Messico 170
EU - Europa 149
AT - Austria 144
BD - Bangladesh 128
PK - Pakistan 113
AR - Argentina 96
ID - Indonesia 91
IQ - Iraq 84
ES - Italia 79
JP - Giappone 63
KR - Corea 53
ZA - Sudafrica 53
IR - Iran 52
EC - Ecuador 50
UZ - Uzbekistan 49
LT - Lituania 47
BE - Belgio 44
CO - Colombia 44
SK - Slovacchia (Repubblica Slovacca) 43
VE - Venezuela 43
AE - Emirati Arabi Uniti 41
MA - Marocco 35
SA - Arabia Saudita 34
CH - Svizzera 31
PE - Perù 28
RO - Romania 27
CZ - Repubblica Ceca 26
KE - Kenya 21
AU - Australia 19
JO - Giordania 19
CL - Cile 18
PT - Portogallo 17
UY - Uruguay 17
AM - Armenia 16
EG - Egitto 16
TN - Tunisia 16
JM - Giamaica 15
PH - Filippine 15
AZ - Azerbaigian 14
DZ - Algeria 14
BO - Bolivia 13
IL - Israele 13
TT - Trinidad e Tobago 13
TW - Taiwan 12
NP - Nepal 11
CR - Costa Rica 10
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
MC - Monaco 8
PY - Paraguay 8
BB - Barbados 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
GE - Georgia 7
HN - Honduras 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 6
NI - Nicaragua 6
PA - Panama 6
PS - Palestinian Territory 6
RS - Serbia 6
AL - Albania 5
AO - Angola 5
BH - Bahrain 5
ET - Etiopia 5
GR - Grecia 5
MG - Madagascar 5
MT - Malta 5
NO - Norvegia 5
EE - Estonia 4
HR - Croazia 4
LB - Libano 4
LV - Lettonia 4
NG - Nigeria 4
BY - Bielorussia 3
Totale 88.164
Salva come PNG Salva come JPEG
Città #
Southend 5.518
Singapore 3.786
Woodbridge 2.866
Chandler 2.554
Ann Arbor 2.547
Houston 2.207
Fairfield 1.913
San Mateo 1.857
Chicago 1.621
Beijing 1.588
Falls Church 1.553
Hong Kong 1.472
Dearborn 1.327
Seattle 1.265
Jacksonville 1.192
Ashburn 1.147
Cambridge 1.143
Wilmington 1.143
Moscow 956
Ottawa 943
Los Angeles 900
Salt Lake City 716
Boardman 703
Dublin 701
Stevenage 685
Portsmouth 682
The Dalles 663
Dong Ket 641
Pisa 586
Lawrence 525
Beauharnois 444
Tampa 407
Montréal 406
Munich 397
Buffalo 380
Milan 336
Elk Grove Village 321
Warsaw 314
Santa Clara 303
Brooklyn 280
Rome 278
London 214
San Diego 213
Florence 178
São Paulo 175
Dallas 170
Redwood City 160
Old Bridge 158
Frankfurt am Main 153
Sterling 151
New York 147
Nuremberg 146
Lancaster 145
Helsinki 125
Central District 114
Istanbul 106
Miami 104
Turku 102
Dulles 95
Fremont 91
Lappeenranta 86
Norwalk 85
Rio de Janeiro 79
Bologna 78
Kansas City 77
Washington 76
San Francisco 71
Phoenix 70
Guangzhou 68
Lucca 66
Belo Horizonte 64
Detroit 63
Toronto 62
Genoa 59
Livorno 59
Shanghai 56
Boston 54
Vienna 54
Shenzhen 53
Assago 50
Brasília 48
Amsterdam 47
Stockholm 46
Tashkent 46
Atlanta 44
Bratislava 43
Naples 43
Turin 43
Chennai 42
Düsseldorf 42
Mexico City 42
Tokyo 42
Lauterbourg 41
Montreal 41
Pittsburgh 41
Wayne 41
Curitiba 38
West Jordan 38
Brussels 37
Palermo 37
Totale 54.185
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.718
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.493
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.398
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.187
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 752
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 473
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 328
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 305
La neuropatia diabetica 272
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 264
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 258
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 255
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 249
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 240
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 228
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 223
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 220
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 217
Treating chemoreflex in heart failure: modulation or demolition? 214
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 214
Building medical knowledge from real world registries: The case of heart failure 213
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 212
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 212
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 212
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 212
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 210
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 209
Cartella clinica automatizzata per il reparto di cardiologia 208
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 208
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 206
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 204
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 204
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 203
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 203
An Open System for Managing Long Term ECG Recordings 202
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 202
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 201
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 200
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 198
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 198
Development of an Electronic Medical Record for Patient Care in Cardiology 197
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 196
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 196
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 196
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 196
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 196
Medical record System for Cardiology and Cardiac Surgery 195
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 194
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 193
B-type natriuretic peptide secretion following scuba diving 192
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 192
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 191
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 191
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 190
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 189
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 188
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 188
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 187
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 187
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 187
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 186
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 186
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 184
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 183
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 183
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 182
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 182
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 182
Prediction of the chemoreflex gain by common clinical variables in heart failure 182
Development of an Electronic Medical Record System for the Department of Cardiology 181
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 181
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 181
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 181
Effects of smoking in patients treated with cardiac resynchronization therapy 181
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 180
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 180
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 180
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 180
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 180
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 180
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 179
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 179
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 179
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 179
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 179
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 178
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 178
Cardiac production of C-type natriuretic peptide in heart failure. 177
Update sui biomarcatori nello scompenso cardiaco. 177
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 177
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 177
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 176
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 176
C-type natriuretic peptide and heart failure 175
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 175
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 175
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 175
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 174
Can we measure how hot the plaque is? Not yet, but…. 174
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 174
Totale 25.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 571.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 571.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.798 966 1.246 530 894 633 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/20262.109 2.109 0 0 0 0 0 0 0 0 0 0 0
Totale 89.075